IndustryPayments

SHAHEEN N CHOWDHRY

Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease LAS VEGAS, NV NPI 1104815463

Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease NV Actelion Pharmaceuticals US, Inc. All categories

General Payments — all program years on this page

$7,387.51

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 250
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,622.63 across 50 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $1,622.6350

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Actelion Pharmaceuticals US, Inc. $228.469
NOVARTIS PHARMACEUTICALS CORPORATION $205.2910
CVRx Inc. $176.062
Kiniksa Pharmaceuticals International, plc $173.473
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $126.192
ABIOMED $109.151
Medtronic, Inc. $101.281
BOSTON SCIENTIFIC CORPORATION $95.884
Merck Sharp & Dohme Corporation $64.373
E.R. Squibb & Sons, L.L.C. $60.303
Edwards Lifesciences Corporation $59.962
Amgen Inc. $55.743
AngioDynamics, Inc. $43.931
PFIZER INC. $35.982
ROCHE MOLECULAR SYSTEMS, INC. $24.491
Esperion Therapeutics, Inc. $21.821
Novo Nordisk AS $21.191
GlaxoSmithKline, LLC. $19.071

By program year

Program yearAmountRecords
2018 $2,140.3385
2019 $783.7410
2020 $153.863
2021 $441.8018
2022 $748.3229
2023 $1,496.8355
2024 $1,622.6350

Records — PY2024 (50)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078902113 Actelion Pharmaceuticals US, Inc. $23.10 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078902115 Actelion Pharmaceuticals US, Inc. $23.53 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078902145 Actelion Pharmaceuticals US, Inc. $24.73 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078902173 Actelion Pharmaceuticals US, Inc. $23.17 06/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078902189 Actelion Pharmaceuticals US, Inc. $29.79 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078902237 Actelion Pharmaceuticals US, Inc. $25.24 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078902289 Actelion Pharmaceuticals US, Inc. $26.31 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078902297 Actelion Pharmaceuticals US, Inc. $27.35 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078902321 Actelion Pharmaceuticals US, Inc. $25.24 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1080697420 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $29.65 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1080697424 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $96.54 09/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086725337 Novartis Pharmaceuticals Corporation $24.06 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086725341 Novartis Pharmaceuticals Corporation $19.00 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086725343 Novartis Pharmaceuticals Corporation $19.88 05/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086725351 Novartis Pharmaceuticals Corporation $24.17 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086725353 Novartis Pharmaceuticals Corporation $18.77 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086725355 Novartis Pharmaceuticals Corporation $19.62 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086725357 Novartis Pharmaceuticals Corporation $18.52 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086725365 Novartis Pharmaceuticals Corporation $16.51 06/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086725401 Novartis Pharmaceuticals Corporation $26.32 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086725403 Novartis Pharmaceuticals Corporation $18.44 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092686993 Boston Scientific Corporation $20.94 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092686995 Boston Scientific Corporation $21.28 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092686997 Boston Scientific Corporation $22.53 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092686999 Boston Scientific Corporation $31.13 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1095071044 AngioDynamics, Inc. $43.93 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096614672 Novo Nordisk Inc $21.19 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101523906 E.R. Squibb & Sons, L.L.C. $17.22 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101523988 E.R. Squibb & Sons, L.L.C. $24.06 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101524026 E.R. Squibb & Sons, L.L.C. $19.02 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115507251 Amgen Inc. $14.94 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115507272 Amgen Inc. $20.85 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115507282 Amgen Inc. $19.95 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116383084 GlaxoSmithKline, LLC. $19.07 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117065762 Medtronic, Inc. $101.28 12/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127782178 CVRx, Inc. $89.84 01/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1127782180 CVRx, Inc. $86.22 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1128586801 ROCHE MOLECULAR SYSTEMS, INC. $24.49 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1129431172 Esperion Therapeutics, Inc. $21.82 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131386274 PFIZER INC. $17.81 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131471775 PFIZER INC. $18.17 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138829472 Edwards Lifesciences Corporation $31.50 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138829506 Edwards Lifesciences Corporation $28.46 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141584880 Merck Sharp & Dohme LLC $22.27 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141833137 Merck Sharp & Dohme LLC $20.22 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141915139 Merck Sharp & Dohme LLC $21.88 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142242867 ABIOMED $109.15 11/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154873706 Kiniksa Pharmaceuticals International, plc $25.36 01/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154873820 Kiniksa Pharmaceuticals International, plc $30.22 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154873864 Kiniksa Pharmaceuticals International, plc $117.89 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.